Literature DB >> 24295645

Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening.

Celine Debeuckelaere1, Paul De Munter2, Pascal Van Bleyenbergh3, Walter De Wever4, Gert Van Assche5, Paul Rutgeerts5, Severine Vermeire6.   

Abstract

We present two patients with inflammatory bowel disease who, despite negative tuberculosis screening, developed a de novo tuberculosis infection after the start of anti tumor necrosis factor alpha treatment. We discuss current screening methods and their limitations, the approach after positive screening and the timing to resume anti-TNFα treatment after TB infection. We shortly mention the immune reconstitution inflammatory syndrome (IRIS), described in a few cases after the stop of anti-TNFalpha while treating the tuberculosis infection. We conclude with some remaining questions concerning tuberculosis in IBD patients.
Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-TNFα; Anti-tuberculous therapy; De novo tuberculosis; IBD; Immune reconstitution inflammatory syndrome; Screening

Mesh:

Substances:

Year:  2013        PMID: 24295645     DOI: 10.1016/j.crohns.2013.11.008

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  15 in total

1.  Imaging of the small intestine in Crohn's disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association.

Authors:  Saurabh Kedia; Raju Sharma; Govind K Makharia; Vineet Ahuja; Devendra Desai; Devasenathipathy Kandasamy; Anu Eapen; Karthik Ganesan; Uday C Ghoshal; Naveen Kalra; D Karthikeyan; Kumble Seetharama Madhusudhan; Mathew Philip; Amarender Singh Puri; Sunil Puri; Saroj K Sinha; Rupa Banerjee; Shobna Bhatia; Naresh Bhat; Sunil Dadhich; G K Dhali; B D Goswami; S K Issar; V Jayanthi; S P Misra; Sandeep Nijhawan; Pankaj Puri; Avik Sarkar; S P Singh; Anshu Srivastava; Philip Abraham; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2018-01-06

2.  Tuberculosis of the breast: an uncommon presentation of an old disease.

Authors:  Maria Antonia Galego; Gisela Lage; Maria Shekhovtsova; Raquel Duarte
Journal:  BMJ Case Rep       Date:  2019-02-22

Review 3.  Immune reconstitution inflammatory syndrome associated with biologic therapy.

Authors:  Malika Gupta; Kashif Jafri; Rebecca Sharim; Susanna Silverman; Sayantani B Sindher; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.919

4.  Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy.

Authors:  Cem Çekiç; Fatih Aslan; Sezgin Vatansever; Firdevs Topal; Elif Sarıtaş Yüksel; Emrah Alper; Ayşe Dallı; Belkıs Ünsal
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

5.  The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers.

Authors:  Ja Min Byun; Chang Kyun Lee; Sang Youl Rhee; Hyo-Jong Kim; Jung-Wook Kim; Jae-Jun Shim; Jae Young Jang
Journal:  J Korean Med Sci       Date:  2015-01-21       Impact factor: 2.153

6.  Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis.

Authors:  Jatinderpal Singh; Amarender S Puri; Sanjeev Sachdeva; Puja Sakhuja; Kulandaivelu Arivarasan
Journal:  Intest Res       Date:  2016-04-27

Review 7.  Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management.

Authors:  Dong Il Park; Tadakazu Hisamatsu; Minhu Chen; Siew Chien Ng; Choon Jin Ooi; Shu Chen Wei; Rupa Banerjee; Ida Normiha Hilmi; Yoon Tae Jeen; Dong Soo Han; Hyo Jong Kim; Zhihua Ran; Kaichun Wu; Jiaming Qian; Pin-Jin Hu; Katsuyoshi Matsuoka; Akira Andoh; Yasuo Suzuki; Kentaro Sugano; Mamoru Watanabe; Toshifumi Hibi; Amarender S Puri; Suk-Kyun Yang
Journal:  Intest Res       Date:  2018-01-18

8.  Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents.

Authors:  Mohammad-Esmaeil Hejazi; Atefeh Ahmadzadeh; Alireza Khabbazi; Aliasghar Ebrahimi; Maryam Farmani; Yasin Hejazi
Journal:  BMC Infect Dis       Date:  2020-07-02       Impact factor: 3.090

Review 9.  Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-07-17

10.  Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study.

Authors:  Aye Aye Thi; Aula Abbara; Sonia Bouri; Simon M Collin; Paul Wolfson; Leah Owen; Kevin G Buell; Laurence John; Ailsa L Hart
Journal:  Frontline Gastroenterol       Date:  2018-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.